Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Apoptosis in the Pathogenesis and Treatment of Disease
Thompson, C. B. (1995) · Science · doi:10.1126/science.7878464 · Cited by 6,524 · cited 1×
“Apoptosis and associated cellular events have profound effect on the progression of benign to malignant phenotype and can be targeted for the therapy of various malignancies including colon cancer (Thompson, 1995; Lowe and Lin, 2000).”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Protective effects of silymarin against photocarcinogenesis in a mouse skin model
Katiyar, S. K., Korman, N. J., Mukhtar, H., & Agarwal, R. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.8.556 · Cited by 355 · cited 1×
“…its crude form known as silymarin) in different animal tumor bioassay systems as well as in cell culture models of epithelial cancers such as skin (Katiyar et al., 1997; Zi et al., 1997; Ahmad et al., 1998; Lahiri-chatterjee et al., 1999), prostate (Zi et al., 1998b; Zi and Agarwal, 1999a;…”
BackgroundSelf-citation
Cited by
Broad targeting of angiogenesis for cancer prevention and therapy
Wang, Z., Dabrosin, C., Yin, X., Fuster, M. M., Arreola, A., Rathmell, W. K., Generali, D., Nagaraju, G. P., El-Rayes, B., Ribatti, D., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.01.001 · Cited by 464
Silybin and silymarin - new effects and applications
Křen, V., & Walterová, D. (2005) · Biomedical Papers · doi:10.5507/bp.2005.002 · Cited by 446
Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
Deep, G., & Agarwal, R. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9237-0 · Cited by 253
Self-citationVolate, S. R., Davenport, D. M., Muga, S. J., & Wargovich, M. J. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi089 · Cited by 253
Potential Applications of NRF2 Modulators in Cancer Therapy
Panieri, E., Buha, A., Telkoparan-Akillilar, P., Cevik, D., Kouretas, D., Veskoukis, A., Skaperda, Z., Tsatsakis, A., Wallace, D., Suzen, S., et al. (2020) · Antioxidants · doi:10.3390/antiox9030193 · Cited by 161
“Silibinin has been shown to decrease metastasis by decreasing the activation of the PI3K-Akt and MAPK (mitogen-activated protein kinase) pathways in the lung [97], and to enhance apoptosis in colon cancer [98].”
BackgroundMechanisms and preclinical efficacy of silibinin in preventing skin cancer
Singh, R. P., & Agarwal, R. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.033 · Cited by 160
“01–1% (w/w) doses to rats for two weeks and silibinin upto 2 g/kg dose for 16 days in SENCAR mice do not result in any adverse change in body weight gain and diet consumption [42].”
BackgroundSelf-citationSilibinin Efficacy against Human Hepatocellular Carcinoma
Varghese, L., Agarwal, C., Tyagi, A., Singh, R. P., & Agarwal, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1646 · Cited by 146
Self-citationFlavonoids: Potential Wnt/beta-catenin signaling modulators in cancer
Amado, N. G., Fonseca, B. F., Cerqueira, D. M., Neto, V. M., & Abreu, J. G. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.05.003 · Cited by 125
Singh, C., Shyanti, R. K., Singh, V., Kale, R. K., Mishra, J. P. N., & Singh, R. P. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.169 · Cited by 56
Self-citation
Metadata
- Authors
- Agarwal, C., Singh, R. P., Dhanalakshmi, S., Tyagi, A. K., Tecklenburg, M., Sclafani, R. A., & Agarwal, R.
- Venue
- Oncogene
- Published
- 2003-11-13
- Volume
- 22
- Issue
- 51
- Pages
- 8271-8282
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2038784909
- Cited by
- 226
- References
- 4
- FWCI
- 9.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.